Piper Sandler analyst David Westenberg reiterated an Overweight rating on Neogenomics (NASDAQ: NEO).The analyst commented: "NEO Is Winning the Community ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments